← Back to Patent Explorer
US4419340A Expired / Lapsed US ⏱️ 0.0 years remaining

Controlled release of anticancer agents from biodegradable polymers

Assignee: University of Delaware
•
Filing: 1980-11-20
•
Granted: 1983-12-06
•
Expires: 2000-11-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polymeric articles for controllably dispensing anticancer agents are disclosed which are formed from biodegradable polymeric materials containing the agents.

Inventors

  • 👤 Seymour Yolles

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:18
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K9/0034; A61K9/0039; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027; A61K9/70; A61K9/7007; A61M; A61M31/00; A61M31/002

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 89 words
An implant drug dispensing device article for prolonged administration upon implantation of an anticancer agent which comprises, a solid shaped article formed from a combination of (a) a biodegradable polymer selected from poly(lactic acid) or polyglycolic acid, and, substantially uniformly and intimately dispersed throughout portions of the article, (b) cis-dichlorodiammine-platinum (II), and (c) doxorubicin or cyclophosphamide each being present in administrable doseage being much larger than those normally toxic, to lower than are normally infused by injection, and having an average particle size of from 150 to 425 microns.
Claim 2
Dependent Claim 89 words
An implant drug dispensing device article for prolonged administration upon implantation of an anticancer agent which comprises, a solid shaped article formed from a combination of (a) a biodegradable polymer selected from poly(lactic acid) or polyglycolic acid, and, substantially uniformly and intimately dispersed throughout portions of the article, (b) cis-dichlorodiammine-platinum (II), and (c) doxorubicin or cyclophosphamide each being present in administrable doseage being much larger than those normally toxic, to lower than are normally infused by injection, and having an average particle size of from 150 to 425 microns.
Claim 3
Dependent Claim 12 words
The article of claim 1 wherein the biodegradable polymer is poly(lactic acid).
Claim 4
Dependent Claim 28 words
A method of treating cancer in a mammal susceptible to treatment with cis-dichlorodiammine-platinum (II) comprising implanting an article according to claim 1 into the body of said mammal.

References Cited (Backward Citations)

US3887699A Cited
US3773919A Cited
US3904663A Cited
US3991766A Cited
US3976071A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-12-05 1987-06-06 1987-12-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-12-05 1991-06-06 1991-12-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-12-05 1995-06-06 1995-12-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag